logo-loader
Cello Health PLC

finnCap sets 145p price target on Cello Health shares in wake of recent ‘good’ full-year 2018 results

“We reiterate our view that the market backdrop for Cello’s technically based, strategic advisory services is strong and defensive, supporting good growth prospects,” finncap's analysts said

Healthcare
In late afternoon trading, Cello Health shares were changing hands at 124.50p each, up 0.4% on Tuesday’s close

finnCap has set a target price of 145p per share on Cello Health PLC (LON:CLL) in the wake of the global healthcare-focused advisory group’s recent full-year results.

In a note to clients, analysts at the ‘house’ broker said: “Cello reported a good set of FY 2018 results with net fees +2%, PBT +6%, EPS +14% (aided by lower tax), DPS +10% and net cash £6.3m up from £1.6m last year.”

READ: Cello is confident of a strong performance in 2019

They pointed out that Cello’s 2017 acquisitions continued to perform well and the Health division broadened and deepened its client offering once again.

Looking forward, the analysts added, the focus will remain on growing the group’s presence in the US and leveraging Signal’s digital capability into the healthcare sector.

They concluded: “We reiterate our view that the market backdrop for Cello’s technically based, strategic advisory services is strong and defensive, supporting good growth prospects.”

In late afternoon trading, Cello Health shares were changing hands at 124.50p each, up 0.4% on Tuesday’s close.

Quick facts: Cello Health PLC

Price: £1.23

Market: AIM
Market Cap: £130.49 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cello Health PLC named herein, including the promotion by the Company of Cello Health PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Equals Group PLC raises £16mln for acquisitions

Top stories from the Proactive UK newsroom. E payments group Equals (LON:EQLS) is to raise £16mln though a placing and open offer to give it some firepower to make acquisitions and accelerate the development of its corporate product.  Healthcare marketing group Cello Health (LON:CLL)...

on 16/8/19

2 min read